TMC Life Sciences (KLSE:TMCLIFE) said its profit attributable to owners plunged to 2.9 million ringgit in the fiscal first quarter ended Sept. 30 from 15.1 million ringgit a year earlier.
Earnings per share fell to 0.0017 ringgit, from 0.0087 ringgit a year ago, according to a Monday bourse disclosure.
Revenue shrank to 82 million ringgit from 92.4 million ringgit a year ago, the healthcare services provider said.
The board did not recommend a dividend for the period.
The company is a unit of Thomson Medical Group (SGX:A50).